Clinical Trials Logo
  1. Home
  2. Hepatitis D, Chronic
  3. NCT05461170

SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.

Hepatitis D, Chronic Clinical Trial

Official title:
A Phase 2 Study to Evaluate Efficacy, Safety and Tolerability of VIR-2218 and VIR-3434 in Participants With Chronic Hepatitis D Virus Infection (SOLSTICE)

Clinical Trial Summary

This is a phase 2 trial in which participants with chronic hepatitis D virus (HDV) infection will receive VIR-2218 and/or VIR-3434 and be assessed for safety, tolerability, and efficacy

Clinical Trial Description

Participants may be enrolled into Cohort 1 (1a and 1b) or Cohort 2 (2a, 2b1 or 2b2, 2c), 3, 4, and 5. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05461170
Study type Interventional
Source Vir Biotechnology, Inc.
Contact Study Inquiry
Phone 415-654-5281
Email clinicaltrials@vir.bio
Status Recruiting
Phase Phase 2
Start date September 17, 2022
Completion date August 2029
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04535544 - A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus Phase 2
Completed NCT02732639 - A Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD) Phase 3
Completed NCT02731131 - A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD) Phase 2
Completed NCT02765802 - A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection Phase 2
Active, not recruiting NCT05229991 - Once Daily Dosing of Lonafarnib Co-administered With Ritonavir for Treatment of Chronic Hepatitis D Virus Infection Phase 3
Terminated NCT01861444 - An Observational Study on the Prevalence of Chronic Hepatitis D in Romania and the Efficacy of Treatment With Pegasys (Peginterferon Alfa-2a) N/A
Active, not recruiting NCT03105310 - Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D Phase 2
Recruiting NCT04166266 - Observatory of Efficacy and Safety of Bulevirtide in Patients With Chronic HBV/HDV Co-infection
Completed NCT01088659 - A Study of Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D. Phase 3
Completed NCT00686790 - Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603) Phase 3
Completed NCT02876419 - A Long Term Follow-up Study of Patients From the REP 301 Protocol